Millennium Management’s Medicines Co MDCO Stock Holding History

Millennium Management’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-600,000	Closed	-$30M	–	4856
2019 Q3	$30M	Buy	+600,000	New	+$23.9M	0.05%	557
2017 Q3	–	Sell	-131,300	Closed	-$4.99M	–	4063
2017 Q2	$4.99M	Buy	131,300 +111,300	+557%	+$4.96M	0.01%	1510
2017 Q1	$978K	Buy	+20,000	New	+$912K	﹤0.01%	2412
2014 Q3	–	Sell	-150,800	Closed	-$4.38M	–	4146
2014 Q2	$4.38M	Sell	150,800 -46,200	-23%	-$1.23M	0.01%	1295
2014 Q1	$5.6M	Buy	+197,000	New	+$6.52M	0.02%	1150

Other funds holding MDCO

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Millennium Management's MDCO Position: Q1 2020 in Review

Millennium Management sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 1,291,001 shares — an estimated $110M sold.

Millennium Management first reported a position in MDCO in Q2 2013 and held it in 24 quarters. The position peaked at $110M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

Millennium Management reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
Millennium Management sold 1,291,001 Medicines Co shares in Q1 2020, an estimated $110M.
Millennium Management first reported a position in Medicines Co in Q2 2013 and held it in 24 quarters.
Millennium Management's Medicines Co position peaked at $110M in Q4 2019.
1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Millennium Management's 13F filing for Q1 2020, filed 14 May 2020.